JL Molitor

540 total citations
9 papers, 430 citations indexed

About

JL Molitor is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, JL Molitor has authored 9 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in JL Molitor's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). JL Molitor is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). JL Molitor collaborates with scholars based in France and Canada. JL Molitor's co-authors include Christophe Louvet, Aimery de Gramont, Thierry André, M Krulik, Élisabeth Carola, V. Izraël, Jean‐Pierre Lotz, F. Maindrault-Gœbel, M. Luisa García and Pascal Artru and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and La Revue de Médecine Interne.

In The Last Decade

JL Molitor

9 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JL Molitor France 8 357 120 115 74 56 9 430
Nisha L. Jacobs United States 6 201 0.6× 77 0.6× 57 0.5× 51 0.7× 68 1.2× 10 279
M. Bonsignori Italy 10 509 1.4× 162 1.4× 35 0.3× 83 1.1× 42 0.8× 24 602
Johann Dréanic France 10 310 0.9× 136 1.1× 60 0.5× 94 1.3× 35 0.6× 22 434
J Lokich United States 6 342 1.0× 98 0.8× 55 0.5× 87 1.2× 47 0.8× 7 414
A. Fandi France 6 292 0.8× 207 1.7× 57 0.5× 108 1.5× 39 0.7× 7 473
Priyanka Pathak United States 8 206 0.6× 96 0.8× 187 1.6× 155 2.1× 26 0.5× 23 425
Madhavan V. Pillai United States 7 419 1.2× 133 1.1× 49 0.4× 108 1.5× 49 0.9× 15 512
Michael Vaslamatzis Greece 9 152 0.4× 128 1.1× 80 0.7× 48 0.6× 23 0.4× 25 364
Grage Tb United States 5 194 0.5× 68 0.6× 98 0.9× 77 1.0× 30 0.5× 10 306
Konstantinos Papadimitriou Greece 11 136 0.4× 61 0.5× 33 0.3× 72 1.0× 39 0.7× 22 265

Countries citing papers authored by JL Molitor

Since Specialization
Citations

This map shows the geographic impact of JL Molitor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JL Molitor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JL Molitor more than expected).

Fields of papers citing papers by JL Molitor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JL Molitor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JL Molitor. The network helps show where JL Molitor may publish in the future.

Co-authorship network of co-authors of JL Molitor

This figure shows the co-authorship network connecting the top 25 collaborators of JL Molitor. A scholar is included among the top collaborators of JL Molitor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JL Molitor. JL Molitor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pradalier, A, et al.. (2004). Syndrome d’activation macrophagique (syndrome d’hémophagocytose). Pathologie Biologie. 52(7). 407–414. 19 indexed citations
2.
Tournigand, Christophe, May Mabro, JL Molitor, et al.. (2004). Survie à long terme des cancers colorectaux métastatiques sous chimiothérapie par 5-fluoro-uracile. La Revue de Médecine Interne. 25(2). 124–128. 9 indexed citations
3.
Gramont, Aimery de, Christophe Louvet, Thierry André, et al.. (2000). Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Annals of Oncology. 11(11). 1477–1483. 101 indexed citations
4.
Maindrault-Gœbel, F., Christophe Louvet, Thierry André, et al.. (1999). Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). European Journal of Cancer. 35(9). 1338–1342. 235 indexed citations
5.
Molitor, JL, et al.. (1997). Leucémie à grands lymphocytes granuleux T révélée par une uvéite bilatérale: association à une maladie cœliaque. La Revue de Médecine Interne. 18(3). 237–239. 11 indexed citations
6.
Gramont, Aimery de, C. Tournigand, Christophe Louvet, et al.. (1997). Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer.. La Revue de Médecine Interne. 10(18). 769–775. 1 indexed citations
7.
Gramont, Aimery de, C. Tournigand, Christophe Louvet, et al.. (1997). Oxaliplatine, acide folinique et 5-fluorouracile (folfox) en seconde ligne thérapeutique du cancer colorectal métastasé. La Revue de Médecine Interne. 18(10). 769–775. 33 indexed citations
8.
Gramont, Aimery de, Christophe Louvet, Thierry André, et al.. (1997). La modulation du 5-fluorouracile par l'acide folinique dans les cancers colorectaux avancés. La Revue de Médecine Interne. 18. 372s–378s. 10 indexed citations
9.
Molitor, JL, Antonio Llombart‐Cussac, Guinebretière Jm, et al.. (1997). [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature].. PubMed. 84(2). 206–11. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nisha L. Jacobs Breakdown of academic impact, for papers by M. Bonsignori Breakdown of academic impact, for papers by Johann Dréanic Breakdown of academic impact, for papers by J Lokich Breakdown of academic impact, for papers by A. Fandi Breakdown of academic impact, for papers by Priyanka Pathak Breakdown of academic impact, for papers by Madhavan V. Pillai Breakdown of academic impact, for papers by Michael Vaslamatzis Breakdown of academic impact, for papers by Grage Tb Breakdown of academic impact, for papers by Konstantinos Papadimitriou
Rankless by CCL
2026